logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
C

Camillo Porta

international business machines (ibm)

79H指数
990论文数
5.7W被引数
收录论文 306
发表时间
logo
Multimodal predictions of end stage chronic kidney disease from asymptomatic individuals for discovery of genomic biomarkers无症状个体终末期慢性肾脏病的多模态预测以发现基因组生物标志物
errBMC Nephrology
IF2.4
err2026-05-12
err0
PREAI
errRabinovici-Cohen, Simona; Platt, Daniel E.; Iwamori, Toshiya; Guez, Itai; Dey, Sanjoy; Bose, Aritra; Kudo, Michiharu; Cosmai, Laura; Porta, Camillo; Koseki, Akira; Meyer, Pablo
err分享
err收藏
Discovering Predictive Biomarkers in Renal Cell Carcinoma
errEuropean Urology Oncology
IF9.3
err2026-04-24
err0
PREAI
errCamillo Porta; Carlo Ganini; Mimma Rizzo; Laura Cosmai
err分享
err收藏
Cabozantinib and temozolomide in patients with advanced progressive neuroendocrine tumors: a phase 2 study卡博替尼和替莫唑胺在晚期进展性神经内分泌肿瘤患者中的应用：一项II期研究
errNature Communications
IF15.7
err2026-04-10
err0
errOAAI
errMauro Cives; Giuseppina Della Vittoria Scarpati; Ottavia Clemente; Eleonora Lauricella; Alessandra Bracigliano; Giuseppe Badalamenti; Paolo Delrio; Lucia Cannella; Carmine Picone; Anna Ragno; Nada Chaoul; Rosa Della Monica; Annabella Di Mauro; Antonio Pizzolorusso; Joana Sorino; Michela Buonaiuto; Giuseppe Ingravallo; Fernanda Picozzi; Pasquale Pignataro; Gerardo Ferrara; Camillo Porta; Salvatore Tafuto
err分享
err收藏
Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: final analysis of efficacy and safety from the phase III CheckMate 214 trial☆纳武利尤单抗联合伊匹木单抗与舒尼替尼用于晚期肾细胞癌一线治疗的疗效和安全性：III期CheckMate 214试验的最终分析
errAnnals of Oncology
IF65.4
err2026-03-03
err0
errOAAI
errT.K. Choueiri; L. Albigès; D.F. McDermott; H.J. Hammers; B. Escudier; M. Burotto; E.R. Plimack; C. Porta; S. George; T. Powles; F. Donskov; M.B. Atkins; H. Gurney; C.K. Kollmannsberger; M.-O. Grimm; C. Barrios; D. Castellano; V. Grünwald; Y. Tomita; B.I. Rini
err分享
err收藏
Attrition Rates in Metastatic Renal Cell Carcinoma (mRCC) Following First Line Immunotherapy-Based Treatment: Results From the International mRCC Database Consortium (IMDC)在接受基于免疫治疗的一线治疗后转移性肾细胞癌（mRCC）中的患者流失率：来自国际mRCC数据库联盟（IMDC）的结果
errClinical Genitourinary Cancer
IF2.7
err2026-01-01
err0
PREAI
errLemelin, Audreylie; Zarba, Martin; Takemura, Kosuke; Wells, J. Connor; Chehade, Razane El Hajj; Donskov, Frede; Porta, Camillo; De Velasco, Guillermo; Davis, Ian D.; Wood, Lori A.; Pal, Sumanta K.; Hansen, Aaron R.; Tran, Ben; Bjarnason, Georg A.; Li, Haoran; Kanesvaran, Ravindran; Powles, Thomas; Mckay, Rana R.; Choueiri, Toni K.; Heng, Daniel Y. C.
err分享
err收藏
Two-Stage Estimation of Overall Survival in the Phase 3 CheckMate 9ER Trial, Adjusting for the Impact of Subsequent Therapy三阶段估计在III期CheckMate 9ER试验中的总生存期，并调整后续治疗的影响
errOncology and Therapy
IF3.2
err2025-11-15
err0
errOAAI
errMarc-Oliver Grimm; Emma Karim; Venediktos Kapetanakis; Mickael Lothgren; Alessia Ogareva; Pragya Shukla; James Truscott; Camillo Porta
err分享
err收藏
Real-world evidences on adjuvant Pembrolizumab for renal cell carcinoma: results from the multicenter real-world ARON-1 study肾细胞癌辅助性帕博利珠单抗的实证据：多中心真实世界ARON-1研究的结果
errCancer Immunology, Immunotherapy
IF0
err2025-11-14
err0
errOAAI
errRay Manneh Kopp; Francesco Massari; Enrique Grande; Timothy J. Schieber; Yüksel Ürün; Jindřich Kopecký; Javier Molina-Cerrillo; Umberto Basso; Jakub Kucharz; Thomas Büttner; Renate Pichler; Ondrej Fiala; Zin W. Myint; Luca Galli; Tomas Buchler; Mimma Rizzo; Hatice Bolek; Maria T. Bourlon; Vincenza Conteduca; Alvaro Pinto; Alessandro Rizzo; Matteo Rosellini; Giandomenico Roviello; Anca Zgura; Veronica Mollica; Antonia Partl; Ahmet Yildirim; Umut Akova; Sebastiano Buti; Fernando Sabino Marques Monteiro; Andrey Soares; Camillo Porta; Mehmet Asim Bilen; Haoran Li; Matteo Santoni
err分享
err收藏
Risk factors for endocrinological immune-related adverse events in patients with renal cell carcinoma treated with immune checkpoint inhibitors肾细胞癌患者接受免疫检查点抑制剂治疗后发生内分泌学免疫相关不良事件的风险因素
errJournal of Endocrinological Investigation
IF3.5
err2025-11-10
err0
errOAAI
errNicola Marrano; Mariangela Caporusso; Carlo Ganini; Andrea Borraccino; Angelo Cignarelli; Sebastio Perrini; Luigi Laviola; Camillo Porta; Francesco Giorgino; Annalisa Natalicchio
err分享
err收藏
Toxicity-related immunotherapy discontinuation and outcome in patients with advanced renal cell carcinoma treated with immune-based combinations (ARON-1 study)与毒性相关的免疫治疗停药及结局：接受基于免疫联合治疗方案的晚期肾细胞癌患者（ARON-1研究）
errInternational Journal of Cancer
IF4.7
err2025-11-04
err0
PREAI
errJavier Molina-Cerrillo; Giandomenico Roviello; Maria T. Bourlon; Hana Studentova; Ondrej Fiala; Linda Cerbone; Jakub Kucharz; Jawaher Ansari; Annalisa Zeppellini; Tarek Taha; Sebastiano Buti; Yüksel Ürün; Sarah Scagliarini; Haoran Li; Kaisa Sunela; Se Hoon Park; Mimma Rizzo; Anca Zgura; Rita Chiari; Emmanuel Seront; Martina Catalano; Marwan Ghosn; Alessandra Filosa; Andrey Soares; Francesco Massari; Fernando Sabino Marques Monteiro; Enrique Grande; Camillo Porta; Sergio Bracarda; Matteo Santoni
err分享
err收藏
Longitudinal validation of the PROFFIT questionnaire to assess financial toxicity in cancer patients纵向验证PROFFIT问卷以评估癌症患者的财务毒性
errJournal of Cancer Policy
IF2
err2025-10-01
err0
errOAAI
errArenare, L.; Porta, C.; Barberio, D.; Terzolo, S.; Zagonel, V.; Pisconti, S.; Del Mastro, L.; Pinto, C.; Bilancia, D.; Cinieri, S.; Rizzo, M.; Migliaccio, G.; Montesarchio, V.; Del Campo, L.; De Lorenzo, F.; Iannellil, E.; Gitto, L.; Vaccaro, C. M.; Frontini, L.; Giannarelli, D.; Bryce, J.; Iacovino, M. L.; Piccirillo, M. C.; Jommi, C.; Efficace, F.; Riva, S.; Di Maio, M.; Gallo, C.; Perrone, F.
err分享
err收藏
Final analysis of nivolumab plus cabozantinib for advanced renal cell carcinoma from the randomized phase III CheckMate 9ER trial来自随机III期CheckMate 9ER试验的尼鲁单抗联合卡博赞替尼治疗晚期肾细胞癌的最终分析
errAnnals of Oncology
IF65.4
err2025-09-23
err0
errOAAI
errR.J. Motzer; B. Escudier; M. Burotto; T. Powles; A.B. Apolo; M.T. Bourlon; A.Y. Shah; C. Porta; C. Suárez; C.H. Barrios; M. Richardet; H. Gurney; E.R. Kessler; Y. Tomita; J. Bedke; C. Scheffold; M. Askelson; J. Panzica; J. Zhang; M. van Kooten Losio; T.K. Choueiri
err分享
err收藏
HER2-Positive Urothelial Carcinoma: Current Evidence on Targeted Agents and Immunotherapy-Based CombinationsHER2阳性尿路上皮癌：靶向药物和免疫治疗为基础的联合治疗当前证据
errTargeted Oncology
IF4
err2025-07-03
err0
PREAI
errFederica Ciciriello; Gaetano Pezzicoli; Antonello Biasi; Claudia D’Addario; Francesco Salonne; Camillo Porta; Mimma Rizzo
err分享
err收藏
Current status of adjuvant immunotherapy and relapse management in renal cell carcinoma: Insights from a European delphi study肾细胞癌辅助免疫治疗和复发管理的现状：欧洲德尔菲研究的见解
errEuropean Journal of Cancer
IF7.1
err2025-06-07
err0
PREAI
errViktor Grünwald; Axel Bex; Sylvie Rottey; Cristina Suárez; Giuseppe Procopio; Guillermo Velasco; Bohuslav Melichar; Jens Bedke; Lisa Pickering; Mário Fontes-Sousa; Manuela Schmidinger; Aristotelis Bamias; Marine Gross-Goupil; Camillo Porta; Philippe Barthélémy; Bernard Escudier; Laurence Albiges
err分享
err收藏
Pembrolizumab plus Lenvatinib in patients with metastatic Renal Cell Carcinoma: real-world evidences from the international ARON-1 study帕博利珠单抗联合仑伐替尼在转移性肾细胞癌患者中的应用：国际ARON-1研究的真实世界证据
errCANCER IMMUNOLOGY IMMUNOTHERAPY
IF5.1
err2025-05-09
err0
errOAAI
errPorta, Camillo; Massari, Francesco; Taha, Tarek; Grande, Enrique; Bourlon, Maria T.; Kanesvaran, Ravindran; Basso, Umberto; Molina-Cerrillo, Javier; Alonso-Gordoa, Teresa; Myint, Zin W.; Fornarini, Giuseppe; Buttner, Thomas; Park, Se Hoon; Urun, Yueksel; De Giorgi, Ugo; Pichler, Renate; Rescigno, Pasquale; Buchler, Tomas; Studentova, Hana; Melichar, Bohuslav; Ansari, Jawaher; Mollica, Veronica; Kucharz, Jakub; Rizzo, Mimma; Rizzo, Alessandro; Kopp, Ray Manneh; Buti, Sebastiano; Monteiro, Fernando Sabino Marques; Soares, Andrey; Bamias, Aristotelis; Santoni, Matteo
err分享
err收藏
Re: Justine Panian, Caiwei Zhong, Sharon H. Choi, et al. Efficacy of Treatments After Lenvatinib in Patients with Advanced Renal Cell Carcinoma. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2024.11.011
errEuropean Urology Focus
IF5.6
err2025-05-03
err0
PREAI
errViktor Grünwald; Thomas Powles; Thomas E. Hutson; Jens Bedke; Camillo Porta; Robert J. Motzer
err分享
err收藏
Towards a Consensus on the Management of Metastatic Renal Cell Carcinoma: Insights from a European Delphi Study
errEuropean Urology Oncology
IF9.3
err2025-02-08
err0
PREAI
errLaurence Albiges; Marine Gross-Goupil; Philippe Barthélémy; Aristotelis Bamias; Jens Bedke; Axel Bex; Mário Fontes-Sousa; Viktor Grünwald; Bohuslav Melichar; Lisa Pickering; Camillo Porta; Giuseppe Procopio; Sylvie Rottey; Manuela Schmidinger; Cristina Suárez; Guillermo Velasco; Bernard Escudier
err分享
err收藏
Neuroendocrine Tumors: Germline Genetics and Hereditary Syndromes
errCURRENT TREATMENT OPTIONS IN ONCOLOGY
IF4.7
err2025-01-17
err0
PREAI
errLauricella, Eleonora; Chaoul, Nada; D'Angelo, Gabriella; Giglio, Andrea; Cafiero, Concetta; Porta, Camillo; Palmirotta, Raffaele
err分享
err收藏
Biomarker analyses from the phase III randomized CLEAR trial: lenvatinib plus pembrolizumab versus sunitinib in advanced renal cell carcinomaIII期随机CLEAR试验的生物标志物分析：lenvatinib联合pembrolizumab与sunitinib治疗晚期肾细胞癌的比较
errANNALS OF ONCOLOGY
IF65.4
err2024-12-01
err2
errOAAI
errMotzer, R. J.; Porta, C.; Eto, M.; Hutson, T. E.; Rha, S. Y.; Merchan, J. R.; Winquist, E.; Gurney, H.; Gruenwald, V.; George, S.; Markensohn, J.; Burgents, J. E.; Cristescu, R.; Sachdev, P.; Narita, Y.; Huang, J.; Zhao, Z.; Okpara, C. E.; Minoshima, Y.; Choueiri, T. K.
err分享
err收藏
Ongoing Clinical Trials and Future Research Scenarios of Circulating Tumor DNA for the Treatment of Metastatic Colorectal Cancer
errCLINICAL COLORECTAL CANCER
IF3.2
err2024-12-01
err6
PREAI
errRoazzi, Laura; Patelli, Giorgio; Bencardino, Katia Bruna; Amatu, Alessio; Bonazzina, Erica; Tosi, Federica; Amoruso, Brunella; Bombelli, Anna; Mariano, Sara; Stabile, Stefano; Porta, Camillo; Siena, Salvatore; Sartore-Bianchi, Andrea
err分享
err收藏
The future of cellular therapy for the treatment of renal cell carcinoma
errEXPERT OPINION ON BIOLOGICAL THERAPY
IF4
err2024-11-04
err1
PREAI
errChaoul, Nada; Lauricella, Eleonora; Giglio, Andrea; D'Angelo, Gabriella; Ganini, Carlo; Cives, Mauro; Porta, Camillo
err分享
err收藏

研究方向

暂无研究方向
合作学者
合作期刊
D
David Cella
H 指数: 184 · 论文数: 1.9K
T
Toni K. Choueiri
H 指数: 149 · 论文数: 2.4K
F
Fabrice André
H 指数: 148 · 论文数: 1.8K
R
Robert J. Motzer
H 指数: 148 · 论文数: 1.6K
F
Francesco Montorsi
H 指数: 146 · 论文数: 4.1K
查看更多